Symposium
Plenary Hall
Plenary Hall
Wednesday, June 18, 10:50 AM – 12:05 PM
Symposium 13: Modulating the brain with light, sound and electric fields - the future of non-invasive brain stimulation in psychiatry?
While several non-invasive brain stimulation (NIBS) techniques are currently approved for the treatment of psychiatric diseases, recent promising studies on this growing research field introduced new sophisticated developments with encouraging outcomes in and beyond the diagnosis of Major Depressive Disorder (MDD). To provide the best possibly effective and safe treatment to all patients with individual clinical profiles, precise translational research and its early adoption in the clinical routine is urgently needed.
In this symposium, the chairs of the session, will shortly provide an overview of approved as well as experimental NIBS that are currently available for the treatment of psychiatric diseases, and discuss their role in the recommended therapeutic algorithms, especially for MDD.
Next, Libor Ustohal will present examples of potential uses of NIBS based on his expertise in clinical practice and recent research on the effects of repetitive transcranial magnetic stimulation (rTMS) in less common indications. Hereby, he will focus on schizophrenia and borderline personality disorder.
Subsequently, therapeutic effects of NIBS utilizing light and sound will be introduced. Hereby, Georg Kranz will present recent research on Transcranial Pulse Stimulation (TPS) in MDD. This technique has the advantage of stimulating deeper brain regions such as the anterior cingulate or anterior insular cortex, two critical nodes in the pathology across mental disorders.
Finally, Maria Teresa Ferretti will report preclinical data on the use of intermittent light at 60Hz for brain entrainment and its effect on perineuronal net-mediated neuroplasticity in mice, as well as modulation of EEG patterns in healthy human subjects.
Objectives: The present symposium will enable the attendees to gain knowledge on approved as well as experimental NIBS that are currently available for the treatment of psychiatric diseases, as well as their best possibly effective and safe use according to the recommended therapeutic algorithms. A detailed information will be provided for rTMS, TPS, as well as intermittent light at 60Hz for brain entrainment.
In this symposium, the chairs of the session, will shortly provide an overview of approved as well as experimental NIBS that are currently available for the treatment of psychiatric diseases, and discuss their role in the recommended therapeutic algorithms, especially for MDD.
Next, Libor Ustohal will present examples of potential uses of NIBS based on his expertise in clinical practice and recent research on the effects of repetitive transcranial magnetic stimulation (rTMS) in less common indications. Hereby, he will focus on schizophrenia and borderline personality disorder.
Subsequently, therapeutic effects of NIBS utilizing light and sound will be introduced. Hereby, Georg Kranz will present recent research on Transcranial Pulse Stimulation (TPS) in MDD. This technique has the advantage of stimulating deeper brain regions such as the anterior cingulate or anterior insular cortex, two critical nodes in the pathology across mental disorders.
Finally, Maria Teresa Ferretti will report preclinical data on the use of intermittent light at 60Hz for brain entrainment and its effect on perineuronal net-mediated neuroplasticity in mice, as well as modulation of EEG patterns in healthy human subjects.
Objectives: The present symposium will enable the attendees to gain knowledge on approved as well as experimental NIBS that are currently available for the treatment of psychiatric diseases, as well as their best possibly effective and safe use according to the recommended therapeutic algorithms. A detailed information will be provided for rTMS, TPS, as well as intermittent light at 60Hz for brain entrainment.